%D9%87%DB%8C%D8%AF%D8%B1%D9%88%DA%A9%D9%88%D8%B1%D8%AA%DB%8C%D8%B2%D9%88%D9%86-%DB%B1%DB%B7-%D8%A8%D9%88%D8%AA%DB%8C%D8%B1%D8%A7%D8%AAHydrocortisone_17-butyrate%D9%87%DB%8C%D8%AF%D8%B1%D9%88%DA%A9%D9%88%D8%B1%D8%AA%DB%8C%D8%B2%D9%88%D9%86-%DB%B1%DB%B7-%D8%A8%D9%88%D8%AA%DB%8C%D8%B1%D8%A7%D8%AAHidrokortizon_17-butiratHidrokortizon_17-butiratQ5954743
about
Clinical Evaluation of T.R.U.E. TEST® : Safety and EfficacyTrial of Treatment of Atopic Dermatitis With Concurrent Altabax® and Topical Low-Potency Corticosteroids Versus Low-Potency Corticosteroid Mono-therapyLocal Steroid Treatment for Idiopathic Granulomatous Mastitis (LSTIGM)A Study of Crisaborole Ointment 2%; Crisaborole Vehicle; TCS and TCI in Subjects Aged ≥ 2 Years, With Mild-moderate ADEvaluation of the Vasoconstriction Properties of MC2-01 CreamEfficacy and Steroid Sparing Potential Study of DGLA Cream in Early Childhood Patients With Moderate to Severe Atopic DermatitisRapid Recognition of Corticosteroid Resistant or Sensitive SepsisA Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 MutationsLow Dose Corticosteroid Infusion in Vasoplegia After Cardiac Surgery (CORTIVAS-CS)Efficacy and Safety of Relacorilant in Patients With Cortisol-Secreting Adrenal AdenomasTemperament Dimensions and Awakening Salivary Cortisol Levels in ADHD.Tapioca Starch Stimutex AS, Aloe Barbadensis, Rose Hip Oil, Allantoin Comparing With Topical 1% Hydrocortisone CreamDental Anxiety in Children and Salivary Cortisol LevelsEvaluating AVM0703 for Treatment of COVID-19The Role of Stress Neuromodulators in Decision Making Under Risk and Selective Attention to Threat
P4844
Langerhans cells but not monocytes are capable of antigen presentation in vitro in corticosteroid contact hypersensitivityStatistical design for formulation optimization of hydrocortisone butyrate-loaded PLGA nanoparticlesNanoparticle-Based Topical Ophthalmic Gel Formulation for Sustained Release of Hydrocortisone Butyrate[Hydrocortisone 17-butyrate (Locoid), a thirty-year ongoing innovative drug]
P921
Q61914907-E14E5A1F-12B5-45B5-92C7-F3AB4DBC7895Q61980581-7C21F07C-C258-4256-9168-F034CB51772DQ62031664-53209CF3-CF3F-4603-A451-9736D0B79EF8Q62812589-FF1EDB5D-6D6B-4531-AB54-FA9FE08D1AC9Q63593008-BC3C05AC-1237-4647-A533-A4ED7392F985Q63596839-A7F33F96-6EF6-4364-BABC-14BA38A55BA8Q86276064-60F30BF4-C037-4CC3-8429-3D1D0ED51080Q87078300-192502D7-CC23-43B4-8BEB-A1A9B61C4411Q87931904-B2BB5E86-C388-4092-968A-A524D3F5D072Q87932503-512AA952-F8E3-412C-BAED-58E73D886D1BQ89153515-8008B9A8-08A9-499F-BD83-6911F68DB61BQ89153782-192F947B-3D4E-409E-BDFF-24D2AC844322Q90693386-15974F67-81C5-4DBF-9332-C91B5A323A69Q92391965-60ED4606-C83A-4FCE-94F9-D4A9A8555D6FQ92392141-1732A52C-F2DB-4A9E-A4DD-B9098F60C2F7
P4844
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
17-maślan hydrokortyzonu
@pl
Hidrokortizon 17-butirat
@sh
Hidrokortizon 17-butirat
@sr
Hydrocortisone 17-butyrate
@en
هیدروکورتیزون-۱۷-بوتیرات
@azb
هیدروکورتیزون-۱۷-بوتیرات
@fa
type
label
17-maślan hydrokortyzonu
@pl
Hidrokortizon 17-butirat
@sh
Hidrokortizon 17-butirat
@sr
Hydrocortisone 17-butyrate
@en
هیدروکورتیزون-۱۷-بوتیرات
@azb
هیدروکورتیزون-۱۷-بوتیرات
@fa
altLabel
هیدروکورتیزون-17-بوتیرات
@fa
prefLabel
17-maślan hydrokortyzonu
@pl
Hidrokortizon 17-butirat
@sh
Hidrokortizon 17-butirat
@sr
Hydrocortisone 17-butyrate
@en
هیدروکورتیزون-۱۷-بوتیرات
@azb
هیدروکورتیزون-۱۷-بوتیرات
@fa
P592
P6366
P661
P662
P683
P1579
P2017
CCCC(=O)O[C@@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)O)C)C(=O)CO
P2067
432.251189
P231
13609-67-1
P232
P233
CCCC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)CCC34C)O)C)C(=O)CO
P234
1S/C25H36O6/c1-4-5-21(30)31-25 ...... ,18-,19-,22+,23-,24-,25-/m0/s1
P235
BMCQMVFGOVHVNG-TUFAYURCSA-N
P2566
100.033.707
P274
P2840
P3117
DTXSID4045896